BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1034 related articles for article (PubMed ID: 16170957)

  • 1. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus].
    Trujillo-Benavides OE; Baltazar-Montúfar P; Angeles-Garay U; Ramírez-Mendoza P; Navarro-García AM; Paredes-Cruz E; Méndez del Monte R; Guerrero-Hernández M
    Rev Gastroenterol Mex; 2005; 70(1):14-9. PubMed ID: 16170957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.
    Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; Henríquez A
    Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus.
    Loughney T; Maydonovitch CL; Wong RK
    Am J Gastroenterol; 1998 Jun; 93(6):916-9. PubMed ID: 9647018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of intestinal metaplasia in patients with and without peptic strictures.
    Kim SL; Wo JM; Hunter JG; Davis LP; Waring JP
    Am J Gastroenterol; 1998 Jan; 93(1):53-5. PubMed ID: 9448174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's esophagus: prevalence in symptomatic relatives.
    Romero Y; Cameron AJ; Schaid DJ; McDonnell SK; Burgart LJ; Hardtke CL; Murray JA; Locke GR
    Am J Gastroenterol; 2002 May; 97(5):1127-32. PubMed ID: 12017151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
    Triadafilopoulos G; Kaczynska M; Iwane M
    Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
    Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
    Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's esophagus: prevalence and size of hiatal hernia.
    Cameron AJ
    Am J Gastroenterol; 1999 Aug; 94(8):2054-9. PubMed ID: 10445527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's esophagus in children: a consequence of chronic gastroesophageal reflux.
    Dahms BB; Rothstein FC
    Gastroenterology; 1984 Feb; 86(2):318-23. PubMed ID: 6690359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?
    Coenraad M; Masclee AA; Straathof JW; Ganesh S; Griffioen G; Lamers CB
    Am J Gastroenterol; 1998 Jul; 93(7):1068-72. PubMed ID: 9672332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
    Vaezi MF; Falk GW; Peek RM; Vicari JJ; Goldblum JR; Perez-Perez GI; Rice TW; Blaser MJ; Richter JE
    Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population.
    Peng S; Cui Y; Xiao YL; Xiong LS; Hu PJ; Li CJ; Chen MH
    Endoscopy; 2009 Dec; 41(12):1011-7. PubMed ID: 19967617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C; Going J; Neilson L; Mackay C; Stuart RC
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus.
    Eisen GM; Sandler RS; Murray S; Gottfried M
    Am J Gastroenterol; 1997 Jan; 92(1):27-31. PubMed ID: 8995932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of intestinal metaplasia in the gastric cardia.
    El-Serag HB; Sonnenberg A; Jamal MM; Kunkel D; Crooks L; Feddersen RM
    Am J Gastroenterol; 1999 Mar; 94(3):622-7. PubMed ID: 10086641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incongruence between histologic and endoscopic diagnoses of Barrett's esophagus using transnasal esophagoscopy.
    Halum SL; Postma GN; Bates DD; Koufman JA
    Laryngoscope; 2006 Feb; 116(2):303-6. PubMed ID: 16467724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Barrett's esophagus in the general population: an endoscopic study.
    Ronkainen J; Aro P; Storskrubb T; Johansson SE; Lind T; Bolling-Sternevald E; Vieth M; Stolte M; Talley NJ; Agréus L
    Gastroenterology; 2005 Dec; 129(6):1825-31. PubMed ID: 16344051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.